Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

Bradley C. Clark, Justin Georgekutty, Charles I. Berul

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.

Original languageEnglish (US)
Pages (from-to)757-761.e1
JournalJournal of Pediatrics
Volume167
Issue number3
DOIs
StatePublished - Sep 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Fingerprint Dive into the research topics of 'Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients'. Together they form a unique fingerprint.

  • Cite this